MULUNZO Trademark

Trademark Overview


On Tuesday, September 28, 2021, a trademark application was filed for MULUNZO with the United States Patent and Trademark Office. The USPTO has given the MULUNZO trademark a serial number of 97050130. The federal status of this trademark filing is REGISTERED as of Tuesday, October 18, 2022. This trademark is owned by Glaxo Group Limited. The MULUNZO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
mulunzo

General Information


Serial Number97050130
Word MarkMULUNZO
Filing DateTuesday, September 28, 2021
Status700 - REGISTERED
Status DateTuesday, October 18, 2022
Registration Number6878861
Registration DateTuesday, October 18, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 18, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 18, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 25, 2022EXAMINER'S AMENDMENT ENTERED
Saturday, June 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, June 25, 2022EXAMINERS AMENDMENT E-MAILED
Saturday, June 25, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, June 23, 2022ASSIGNED TO EXAMINER
Wednesday, October 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 1, 2021NEW APPLICATION ENTERED